A Study of Dovitinib Versus Sorafenib in Adult Patients With Hepatocellular Carcinoma (HCC) as a First Line Treatment
Clinical trial NCT01232296 · COMPLETED
Trial details
- NCT number
- NCT01232296
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2014-04-01
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.